Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://flynnmzdb431983.onesmablog.com/this-new-drug-retatrutide-australia-a-potential-solution-for-losing-weight-84371236